Clinical pharmacology of the new penicillins. II. Effect of drugs which interfere with binding to serum proteins.
D001241:Aspirin / Q000494:pharmacology*; D001798:Blood Proteins; D003023:Cloxacillin; D004009:Dicloxacillin; D006801:Humans; D066298:In Vitro Techniques; D007408:Intestinal Absorption; D008297:Male; D009254:Nafcillin; D010400:Penicillin G; D010404:Penicillin V; D011485:Protein Binding; D013421:Sulfamethoxypyridazine / Q000494:pharmacology*; D013432:Sulfathiazoles / Q000494:pharmacology*; D014556:Urine
D001798:Blood Proteins; D013432:Sulfathiazoles; D009254:Nafcillin; D004009:Dicloxacillin; D003023:Cloxacillin; D010400:Penicillin G; D001241:Aspirin; D013421:Sulfamethoxypyridazine; D010404:Penicillin V